The Drug-coated Balloons Market Size is valued at 594.0 Million in 2022 and is predicted to reach 1301.8 Million by the year 2031 at a 9.2 % CAGR during the forecast period for 2023-2031.
A drug-coated balloon (DCB) is defined as a semi-compliant angioplasty balloon layered with a cytotoxic chemotherapeutic agent. At present, paclitaxel-coated balloons are gaining popularity in commercial applications. In recent years, drug-coated balloons have emerged as a stimulating technology developed to modify the limitations challenged by drug-eluting stents and are further expected to prove effective in complex subsets. Numerous drug-coated balloons identified for coronary and peripheral applications were estimated recently in preclinical and clinical studies with encouraging results.
The market is anticipated to be driven by rising technological advancements coupled with increased demand for minimally invasive surgery. The growing prevalence of Peripheral and coronary artery diseases across the globe is also considered as one of the major factors driving the market. Rapidly augmenting geriatric population with cardiovascular diseases, huge patient base in developing countries, and cumulative investments in R&D for treatment of peripheral and coronary artery diseases are the are other significant factors driving the market growth.
Market Segmentation
The global Drug-Coated Balloons Market is categorized on the basis of product, end-user, and region. On the basis of product type, the market is segmented into Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease, and Drug-Coated Balloons for Other Indications. On the basis of end-user, the market is segmented into Hospitals, Cardiac Catherization Labs, and Ambulatory Surgical Centers. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.
Competitive Landscape
Some of The Key Players in The Drug-coated Balloons Market:
- Medtronic
- BD
- Koninklijke Philips
- Braun Melsungen
- BIOTRONIK
- Boston Scientific
- Opto Circuits (India)
- Acotec Scientific
- AR Baltic Medical
- Acrostak
- Biosensors International Group
- Cardionovum
- Concept Medical
- ENDOCOR
- Hexacath
- iVascular SLU
- A. Med Alliance
- Minvasys
- Orchestra BioMed
- QT Vascular
- RD Global-Invamed
- Surmodics
- Terumo
- Wellinq
- Other Prominent Players
The Drug-coated Balloons Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 594.0 Million |
|
Revenue Forecast In 2031 |
USD 1301.8 Million |
|
Growth Rate CAGR |
CAGR of 9.2 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, Cardionovum, Concept Medical, ENDOCOR, Hexacath, iVascular SLU, M.A. Med Alliance, Minvasys, Orchestra BioMed, QT Vascular, RD Global-Invamed, Surmodics, Terumo, Welling, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
